Binding and Release of FeIII Complexes from Glucan Particles for the Delivery of T1 MRI Contrast Agents

被引:21
|
作者
Patel, Akanksha [1 ]
Asik, Didar [1 ]
Snyder, Eric M. [1 ]
Dilillo, Alexandra E. [1 ]
Cullen, Paul J. [2 ]
Morrow, Janet R. [1 ]
机构
[1] Univ Buffalo State Univ New York, Dept Chem, Buffalo, NY 14260 USA
[2] Univ Buffalo State Univ New York, Dept Biol, Buffalo, NY 14260 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
acid-mediated release; beta-glucan microparticles; biocompatible delivery; chelator-mediated release; imaging agents; targeted delivery; METAL-COMPLEXES; IRON; RELAXATION; LIPOSOMES; RIFABUTIN; MALTOL;
D O I
10.1002/cmdc.202000003
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Yeast-derived beta-glucan particles (GPs) are a class of microcarriers under development for the delivery of drugs and imaging agents to immune-system cells for theranostic approaches. However, the encapsulation of hydrophilic imaging agents in the porous GPs is challenging. Here, we show that the unique coordination chemistry of Fe-III-based macrocyclic T-1 MRI contrast agents permits facile encapsulation in GPs. Remarkably, GPs labeled with the simple Fe-III complexes are stable under physiologically relevant conditions, despite the absence of amphiphilic groups. In contrast to the free Fe-III coordination complex, the labeled Fe-III-GPs have lowered T-1 relaxivity and act as a silenced form of the contrast agent. Addition of a fluorescent tag to the Fe-III complex produces a bimodal agent to further enable tracking of the nanoparticles and to monitor release. Treatment of the iron-labeled GPs with a maltol chelator or with mildly acidic conditions releases the intact iron complex and restores enhanced T-1 relaxation of the water protons.
引用
收藏
页码:1050 / 1057
页数:8
相关论文
共 50 条
  • [1] A Class of FeIII Macrocyclic Complexes with Alcohol Donor Groups as Effective T1 MRI Contrast Agents
    Snyder, Eric M.
    Asik, Didar
    Abozeid, Samira M.
    Burgio, Ariel
    Bateman, Gage
    Turowski, Steven G.
    Spernyak, Joseph A.
    Morrow, Janet R.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, 59 (06) : 2414 - 2419
  • [2] Nanostructured T1 MRI contrast agents
    Na, Hyon Bin
    Hyeon, Taeghwan
    JOURNAL OF MATERIALS CHEMISTRY, 2009, 19 (35) : 6267 - 6273
  • [3] Paramagnetic inorganic nanoparticles as T1 MRI contrast agents
    Lee, Soo Hong
    Kim, Byung Hyo
    Na, Hyon Bin
    Hyeon, Taeghwan
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2014, 6 (02) : 196 - 209
  • [4] A model for MRI contrast enhancement using T1 agents
    Ahrens, ET
    Rothbächer, U
    Jacobs, RE
    Fraser, SE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) : 8443 - 8448
  • [5] Paramagnetic nanoparticle T1 and T2 MRI contrast agents
    Xu, Wenlong
    Kattel, Krishna
    Park, Ja Young
    Chang, Yongmin
    Kim, Tae Jeong
    Lee, Gang Ho
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2012, 14 (37) : 12687 - 12700
  • [6] Chemistry of Tumour Targeted T1 Based MRI Contrast Agents
    Kamaly, Nazila
    Miller, Andrew D.
    Bell, Jimmy D.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (12) : 1158 - 1183
  • [7] Development of macrocyclic Fe(III) T1 MRI contrast agents
    Asik, Didar
    Snyder, Eric
    Spernyak, Joseph
    Morrow, Janet
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [8] Sensitive MRI detection of internalized T1 contrast agents using magnetization transfer contrast
    Castelli, Daniela Delli
    Ferrauto, Giuseppe
    Di Gregorio, Enza
    Terreno, Enzo
    Aime, Silvio
    NMR IN BIOMEDICINE, 2015, 28 (12) : 1663 - 1670
  • [9] The Challenge of T1 Contrast Agents for High-Magnetic Field MRI
    Helm, Lothar
    CHIMIA, 2011, 65 (09) : 696 - 698
  • [10] Shape-controlled MnO nanoparticles as T1 MRI contrast agents
    Banerjee, A.
    Zeng, W.
    Taheri, M.
    Blasiak, B.
    Tomanek, B.
    Trudel, S.
    AIP ADVANCES, 2019, 9 (12)